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PURPOSE. To measure macular pigment (MP) and find possible correlation between
heterochromatic flicker photometry (HFP) and quantitative autofluorescence (qAF) in young
healthy subjects.
METHODS. We enrolled 80 eyes of 40 young healthy subjects. Macular pigment optical density
(MPOD) was automatically calculated with a macular pigment screener (MPS; MPODHFP). We
calculated qAF comparing gray levels (GL) of qAF images with GL of internal reference of a
confocal scanning laser ophthalmoscopy. A raster of concentric rings was used to
automatically calculate foveal qAF (qAFF) values (08–1.28); inner ring (1.38–4.38; qAF3);
middle ring (4.58–78; qAF6); and outer ring (7.28–9.78; qAF8). The test-retest coefficient of
repeatability was calculated with Bland-Altman method. The between-eyes coefficient of
agreement and correlation between the two techniques were calculated. Finally, an
estimation of MPOD from qAF was performed (MPOD-AF), to find possible direct correlations
with MPODHFP obtained with the MPS II.
RESULTS. Paired data sets of repeated measurements were not statistically different for MPS II
(P ¼ 0.66); log qAFF (P ¼ 0.95); log qAF3 (P ¼ 0.48); log qAF6 (P ¼ 0.4); and log qAF8 (P ¼
0.56). Stepwise regression analysis showed negative correlation between MPS II and log qAFF
values (R2 ¼ 0.35) with Spearman coefficient (q) of 0.60 (P < 0.01) and log qAF3 (R2 ¼
0.18; q ¼ 0.38.; P < 0.01). No correlation was found between MPS II and log qAF6 (q ¼
0.01, P ¼ 0.93), neither with log qAF8 (q ¼ 0.05, P ¼ 0.66).
CONCLUSIONS. In young healthy subjects, a negative correlation between qAF values and
MPODHFP was found in the central degrees. However, qAF and HFP do not seem to be
interchangeable: they represent two opposite ways of estimating MP.
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Macular pigment is mainly composed of carotenoidpigments (lutein, zeaxanthin, and meso-zeaxanthin).
Macular pigment has a spatial distribution corresponding
approximately to the area of the foveal avascular zone and
characteristically decreases at approximately 58 to 88 eccen-
tricity.1–3 Macular pigment is maximally located at the level of
the inner plexiform layer and Henle’s fiber layer of the human
macula and has peculiar short wavelength (blue) light filtering
and antioxidant properties.4–6 Besides its effect in normal
subjects (reduction of glare disability and chromatic aberra-
tion), macular pigment seems to protect against AMD.7,8
Therefore, the detection and quantification of MP has become
important.9 Several techniques are available for measuring MP,
both in vivo and ex vivo.4,5,10 In vivo modalities include
physical (e.g., dual-wavelength fundus autofluorescence, fun-
dus reflectometry, and Raman spectroscopy) and psychophys-
ical (e.g., HFP, customized [c]HFP, color matching, and motion
photometry) techniques. In particular, HFP is a psychophysical
technique used to MPOD by presenting a light stimulus of two
alternating wavelengths (short: absorbed, and long: not
absorbed). The aim of the HFP is to achieve a perception of
no or minimal flicker, that occurs when the luminance of the
two wavelengths appears equal to the observer.11,12
Fundus autofluorescence (FAF) is a physical method used to
detect MP based on the properties of lipofuscin that is normally
present at the level of the human RPE cells and photoreceptors
outer segments.13 Retinal pigment epithelium lipofuscin is
excited in vivo between 400 and 590 nm and emits
autofluorescence at 520 to 800 nm.14 Since MP absorbs light
of 400 to 550 nm and it is located anteriorly to the RPE, macular
autofluorescence is attenuated by MP itself if the excitation
wavelength falls between 400 and 550 nm.
Although there is not yet a technique considered as the
‘‘gold standard’’ for measuring MP, a concordance between MP
density measured by HFP and that measured with the two-
wavelength autofluorescence has already been proven both in
healthy and in AMD eyes.15,16 Even single-wavelength FAF has
been previously employed to detect MP and even if it resulted
less reliable when compared with the double-wavelength
technique especially in peripheral areas, it showed high
repeatability and a good agreement between the techniques
was found within the fovea center.17
Quantitative autofluorescence (qAF), recently introduced,
seems a more standardized and repeatable technique compared
to FAF and has been studied in the evaluation of autofluores-
cence in healthy and pathologic eyes.18–20
The aim of the study was to assess the MPOD in a healthy
group of young adults using an HFP technique (MPODHFP) and
to find a possible correlation with quantitative autofluores-
cence measured in the same area.
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METHODS
Subjects
We enrolled 80 eyes of 40 healthy subjects in the study from
the population of staff and students of the University Eye Clinic
of Torino, Italy, between October and December 2015. Mean
(6SD) age of the study population was 25.87 (63.93) years
(range, 20–34 years). They were all Caucasian. All subjects
successfully completed the MP and qAF tests. Demographic
data are provided in Table 1. All subjects were in good general
and ocular health, had clear media with no lens opacities,
normal retinal status, good fixation, and a refractive error from
3.0 toþ 2.0 diopters. Best corrected visual acuity (BCVA) was
20/20 (Snellen equivalent) in all subjects. Exclusion criteria
were familiarity for AMD, smoking, and any kind of therapy
including nutritional supplements.
The tenets of the Declaration of Helsinki were followed,
institutional review board approval was granted, and informed
consent was obtained from all subjects. The retinal light
exposures (recommended maximum power: 280 lW; 308 3
308 field; 488 nm) are below the limits recommended by the
American National Standard Institute (ANSI) standards for
durations up to 8 hours.21,22
Procedures
On the same day, the subjects underwent BCVA exam and
MPODHFP measurement using a macular pigment screener
(MPS II/MPS 9000; Elektron Technology, Cambridge, UK). An
Early Treatment Diabetic Retinopathy Study chart was used to
measure BCVA, expressed as Snellen equivalent. Pupil dilata-
tion was performed after BCVA and MPS II examinations with
topical 1% tropicamide solution and 2.5% phenylephrine. After
30 minutes, in order to obtain adequate mydriasis of at least 7
mm, subjects underwent qAF.
Macular Pigment Measurement
Measurements of MPODHFP were all performed by the same
trained investigator (CL). We used the HFP technology of the
MPS II to measure MPODHFP as described in details else-
where.23,24 Briefly, a light stimulus of two alternating wave-
lengths (blue and green, 465 nm and 530 nm, respectively) was
presented and the subject reported the appearance of flicker as
the temporal frequency of blue-green flickering lights was
reduced.8,25 In other words, the subject registered his first
perception of flicker throughout different blue-green ratios.
Data were taken analyzing the central (08) and peripheral
(88) regions. The target consists of a 18 circular aperture in an
integrating sphere. This is surrounded by a uniformly
illuminated white area subtending approximately 308. The
peripheral measurement is achieved by fixating on a larger
1.758 red spot located at 88 horizontal eccentricity (Figs. 1A,
1B). We then automatically calculated MPODHFP using the
difference between central (08) and peripheral (88) values. The
software of the MPS II uses a new algorithm that automatically
analyzes the results and gives three possible outcomes (accept,
caution, and reject). In order to collect reliable data, we
decided not to approve ‘‘caution’’ and ‘‘reject’’ results. Every
test was repeated twice (with 30-minute intervals between
measurements) to verify the repeatability of the instrument.
When unacceptable results (i.e., ‘‘caution’’ or ‘‘reject’’) were
observed, the test was interrupted and the subject was asked
to repeat it the following day. For example, the MPS II reports
unacceptable results in case of too few data points or shallow
graph, noisy data or flicker too high, as stated in the user
manual. Every subject was able to perform the test and
included for statistical analysis.
TABLE 1. Demographic Data
Subjects enrolled, n 40
Subjects who completed all tests, n 40
Sex, male/female 18/22
Age, y, mean 6 SD (range) 25.87 6 3.93 (20–34)
Race (%) Caucasian (100)
BCVA, Snellen equivalent, mean (range) 20/20 (20/20–20/20)
FIGURE 1. Quantitative fundus autofluorescence image with the scan
pattern centered on the fovea. (A) Only green segments were included
in our analysis: qAFF includes the central area; qAF3 includes the inner
ring; qAF6 includes the middle ring; qAF8 includes the outer ring. (B)
Comparison of the areas analyzed by two devices: green segments
corresponding to an area of 8.58 radius were analyzed by qAF, while the
white dashed circular line delimits an area of 88 radius analyzed by the
MPS II. The white and red circles are the MPS II targets: F is the 18
central target; P is the 1.758 peripheral target.
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Quantitative Fundus Autofluorescence
An experienced operator (MN) acquired all qAF images using a
confocal scanning laser ophthalmoscopy (cSLO) device (Spec-
tralis HRAþOCT; Heidelberg Engineering, Heidelberg, Ger-
many). Quantitative AF incorporates a fluorescence reference
internal to the imaging device so that the reference is part of
the FAF image. Analysis consisted of comparing the gray levels
(GL) of the FAF image with the GL of the internal reference,
accounting thereby for changes in laser power and detector
sensitivity. Furthermore, the Heidelberg acquisition software
includes corrections for magnification and optical media
density from normative data on lens transmission spectra.
Here there is a summary of qAF images acquisition protocol
as detailed description is reported elsewhere.18 Thirty minutes
after pupil dilation, subjects were examined with room lights
turned off and underwent a 20- to 30-second bleaching period
to reduce photopigment absorption.18 The fundus image was
focused to reach maximum FAF signal intensity, and the
detector sensitivity was increased until the cSLO image was as
bright as possible, avoiding nonlinear effects at high GL
(indicated by red pixels). The Heidelberg software limits the
sensitivity setting to a value of 90 to avoid being in the
nonlinear detector realm.
Three images (each of 12 frames, in video format) were
recorded with room lights turned off in the high speed mode
(8.9 frames/second) within a 3083308 field (7683768 pixels).
Images were obtained within a session (~3–6 seconds apart)
using the same positioning in the chin/head rest, alignment of
the camera, focus, and sensitivity. After image acquisition, the
quality of subject fixation was clinically evaluated by the mean
of a target positioned at 40 cm, together with the resolution of
each image. All patients presented with good fixation.
At the end of the examination image quality was verified
according to the qAF analysis software manual, (Spectralis
Quantitative Autofluorescence Analysis Software User Manual,
Software, version 6.0; Heidelberg Engineering) and the first
two exams, if acceptable, were used to test instrument
repeatability. Every frame inside each video was aligned and
averaged with the system software and saved to create the
images for analysis.
To determine qAF, images were exported from a commer-
cial software program (Heidelberg Eye Explorer; Heidelberg
Engineering) to a custom-made image analysis program
(Heidelberg Engineering), which was developed according to
the software created by Francois Delori (IGOR; WaveMetrics,
Lake Oswego, OR, USA).18 The software allowed us to draw a
raster that consists of four concentric rings of segments around
the foveal area (Fig. 1A). The pattern was centered on the fovea
and its peripheral margin was tangential to the temporal edge
of the optic disc: the distance between them was defined as
foveal distance (FD). For each segment, qAF was automatically
computed from the mean GL in that segment and the GL of the
internal reference.18 The software accounted for the presence
of vessels in the segments.
The average FD, used to define the measurement areas, was
12.38 (visual field degrees). The central circle (fovea) had a
radius of 1.28. The radii of the centerlines for the inner, middle,
and outer rings were respectively 2.88, 5.78, and 8.58. The
mean difference in radius between the area analyzed by the MP
II and the area analyzed by qAF6 (middle ring) is 0.48 (Fig. 1B).
Four measurements were obtained from each image (Fig.
1A): qAF of the central foveal area (qAFF); mean qAF between
the four segments of the inner ring (qAF3); mean qAF between
the eight segments of the middle ring (qAF6) and mean qAF
between the eight segments of the outer ring (qAF8). The more
external ring was not included in our correlation analysis.
Data Analysis and Statistics
All data are presented as mean 6 standard deviation. The
Shapiro-Wilk test was used to verify the normal distribution of
data.26 Differences between data sets were evaluated with
paired t-tests. A value of P < 0.05 was considered significant.
Statistical analyses were conducted using commercial software
(SPSS 19.0; SPSS, Inc., Chicago, IL, USA).
Repeatability. Test–retest repeatability and between-in-
strument agreement between measurements were analyzed
using the Bland-Altman method.27 The coefficient of repeat-
ability (CR) was calculated as:
CRMPOD ¼ 61:963 rMPOD2MPOD1 ð1Þ
CRqAFF ¼ 61:963 rlog qAF2ð ÞlogðqAF1Þ; ð2Þ
where MPODHFP1 and MPODHFP2, and qAF1 and qAF2 are
respectively the two measurements made for each eye; r is the
standard deviation. As previously described,19 we used
log(qAF) instead of qAF in all analysis. The same formula was
used to calculate repeatability of qAF3, qAF6, and qAF8.
Agreement Between Eyes. Between-eyes coefficient of
agreement (CA) was calculated as:
CAMPODHFP ¼ 61:96rMPODHFPODMPODHFPOS ð3Þ
CAqAFF ¼ 61:96rlog qAFODð Þlog qAFOSð Þ; ð4Þ
where MPODHFP and log qAFð Þ are the mean values of
MPODHFP1 and MPODHFP2, log(qAF1) and log(qAF2), respec-
tively. The same formula was used to calculate agreement
between eyes of qAF3, qAF6, and qAF8.
Correlation Between qAF and MPOD. With an expected
correlation coefficient of 0.5 and a significance level of 0.05,
we estimated a sample size of 38 eyes to reach a statistical
analysis power of 0.9.28 Regression analysis and Spearman
coefficient were used to calculate the correlation between
each log: qAFF, qAF3, and qAF6 with MPODHFP .
We also estimated MPOD values from qAFF, as previously
described 17, using the formula:
MPODAF ¼ 1
Kð488Þ
3 log

qAF8
qAFF

; ð5Þ
where K(488) (0.781) is the known extinction coefficient of the
MP at 488 nm, relative to the extinction coefficient at 460
nm.29 The same formula was used to estimate MPOD from
qAF3 and qAF6. We then correlated all MPODAF with
MPODHFP.
RESULTS
Using the Shapiro-Wilk test, all data resulted normally
distributed (P > 0.05).
Repeatability and Agreement Between Eyes
Main results are summarized in Table 2. Mean MPODHFP was
0.47 6 0.1 optical density units (DU). Mean log qAFð Þ was 1.66
6 0.17 for log qAFF, 1.92 6 0.12 for log qAF3, 2.32 6 0.13 for
log qAF6, and 2.31 6 0.12 for log qAF8. We found CR was
60.17 for the MPS II and 60.031, 60.013, 60.018, and
60.013 for log qAFF, log qAF3, log qAF6, and log qAF8,
respectively (Fig. 2).
Paired data sets of repeated measurements were not
statistically different for the MPS II (P ¼ 0.66); log qAFF (P ¼
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0.95); log qAF3 (P¼0.48); log qAF6 (P¼0.4); and log qAF8 (P¼
0.56).
Paired data sets of measurements for the two eyes were not
statistically different for the MPS II (P ¼ 0.93); log qAFF (P ¼
0.95); log qAF3 (P¼ 0.52); log qAF6 (P¼ 0.75); and log qAF8 (P
¼ 0.35), with CA of 60.51 (MPODHFP), 60.11 log qAFF units,
60.16 log qAF3 units, 60.17 log qAF6 units, and 60.15 log
qAF8 units.
Correlation Between qAF and MPOD
A stepwise regression analysis showed a negative correlation
between MPODHFP and log qAFF (coefficient of determination,
R2 ¼ 0.35) and log qAF3 (R2 ¼ 0.18) with a Spearman
coefficient (q) of 0.60 (P < 0.01) and P ¼0.38 (P < 0.01),
respectively. No correlation was found neither between
MPODHFP and log qAF6 (q ¼ 0.01, P ¼ 0.93) nor between
MPODHFP and log qAF8 (q ¼ 0.05, P ¼ 0.66; Fig. 3). Mean
MPODAF was 0.82 6 0.25 from qAFF, 0.5 6 0.21 from qAF3
and 0.01 6 0.04 from qAF6. It showed a positive correlation
with MPODAF values in the foveal area (R
2 ¼ 0.23) with q ¼
0.49 (P < 0.0001) and in the inner ring (R2 ¼ 0.12) with q ¼
0.32 (P < 0.01) but not in the middle ring (R2¼ 0.01) with q¼
0.13 (P ¼ 0.22; Fig. 4)
DISCUSSION
Macular carotenoids (lutein, zeaxanthin, and meso-zeaxanthin)
are gaining an increasing interest among scientists and
clinicians, since their correlation with retinal pathologies such
as age-related macular degeneration has been widely studied
and evaluated.30–33 However, in order to verify their potential
contribution to the natural history of macular disease, a valid,
reliable, and simple measurement technique of these pigments
would be needed. Several MP-measuring devices are available
and psychophysical techniques claim to be the most accurate
and reproducible.
In the present study, we evaluated the concordance of two
MP-measuring devices (MPS II and qAF) in young healthy
subjects. Repeatability was also calculated for both instru-
ments, and new coefficient of repeatability was investigated in
more eccentric parafoveal areas (qAF3, qAF6, and qAF8). In
particular, the coefficient of repeatability for MPODHFP was
0.17. This was similar to what previously reported for
MPODHFP measured with MPS II/MPS9000 ranging between
0.19 and 0.33.34
Although recently introduced, qAF has already demonstrat-
ed good reproducibility both in healthy and pathologic
eyes.19,20 In our study, we observed good reproducibility in
all analyzed areas of the scan pattern. The within-session
repeatability for the qAF in the foveal area (qAFF) was 7.4%,
comparable to that reported by Delori et al.18 (6.9%). In the
more peripheral areas (qAF3, qAF6, and qAF8) the within-
session repeatability was 3%, 4.2%, and 3% respectively. Since it
has not been investigated before, no comparison was possible
for the peripheral areas.
In this study, we investigated the potential correlation
between MP measurements obtained with the MPS II
technology and quantitative measurements of the autofluores-
cence (qAF). Interestingly, a negative and statistically signifi-
cant correlation between MPODHFP and log (qAF) has been
found in the central area up to approximately 4.38 (0.60 and
0.38, for the qAFF and qAF3 respectively; P < 0.01), while in
the more eccentric region (qAF6) no correlation was found.
This negative correlation mainly relies on the high concentra-
tion of macular pigment in the foveal area, absorbing the FAF
blue-light masking retinal fluorophores, while the lack of
correlation found between qAF6 and MPODHFP is probably due
to the decrease in macular pigment concentration from the
foveal region to more peripheral areas. The investigated area,
which is a function of the radius of the chosen reference,
critically improves its dimensions compared to qAF3, making of
the more peripheral segments the most consistent part to
determine the mean qAF. Although several factors can
influence retinal pigment distribution (which in the 40% of
healthy eyes does not follow a Gaussian distribution),3 our
results suggest that qAF values can be able to reflect its
concentration. In particular, the lower are the values of qAF,
the higher is the concentration of MP. A direct estimate of
MPOD from qAF values (Equation 5), in order to directly
compare the values with those from the MPS II, was also
performed. In the qAFF area, MPODAF was 0.82 DU, compared
to 0.47 DU obtained with the HFP, This discrepancy can be
partially explained by the different sampling apertures of the
instruments (18 and 2.48 diameter for HFP and qAF, respective-
ly) and by the intrinsic limit of the single-wavelength AF, that
provides AF values from MP and even the RPE, resulting in an
overestimation of the measurements. Delori et al.18 estimated
that the fluorescence in the fovea was on average 61% 6 9% of
its value at 78 temporal. By applying a correction formula to
consider the gap between foveal and peripheral AF values due
to lipofuscin autofluorescence, MPODAF values were reduced
to 0.54 DU, more similar to those obtained with HFP
technique. Although the formula for direct MPOD estimation
is suitable for double-wavelength systems, a positive correla-
tion between qAFF and MPS II MPOD values was found,
somehow enforcing our findings and suggesting its possible
employment in the clinical practice.
Several studies compared physical such as dual-wavelength
autofluorescence and psychophysical (heterochromatic flicker
photometry) techniques for the measurement of MP.13,15,34 In
particular, MP values measured with the dual-wavelength
autofluorescence OCT device (Heidelberg Engineering) were
comparable to MP values obtained using the densitometer in
subjects free of retinal diseases.34 However, these findings
were not confirmed in subjects with retinal changes secondary
to early AMD.15 The correlation between these two techniques
varies also according to the area where the measurements
were taken, constantly decreasing moving away from the
TABLE 2. Statistical Analysis Showing the Results of Test-Retest Repeatability, CR, and COA Between the Two Techniques of MP Measurement (HFP
and qAF)
Technique* Mean 6 SD CR P Value (X1) vs. (X2) P Value X¯OD vs. X¯OS CA
MPS II 0.47 6 0.1 60.17 0.66 0.93 60.51
log qAFF 1.66 6 0.17 60.031 0.95 0.95 60.11
log qAF3 1.92 6 0.12 60.013 0.48 0.52 60.16
log qAF6 2.32 6 0.13 60.018 0.4 0.75 60.17
log qAF8 2.31 6 0.12 60.013 0.56 0.35 60.15
X1 and X2, first and second measurement respectively; X¯OD and X¯OS, mean values in the right and left eye, respectively.
* The values of MPS II are expressed in optical DUs. Log qAF values are expressed in log qAF units.
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fovea.15 In fact, although these technologies are designed to
measure MP, each device works on different methodological
approach, with different advantages and limitations. Even if at
present qAF is mainly used for experimental research, its
diffusion is encouraged and it will probably become a useful
clinical technique in the evaluation and management of retinal
diseases. Compared to FAF, it offers quantification of measure-
ments and enables the ophthalmologist to evaluate predefined
areas. However, unlike traditional validated MPOD-detecting
techniques, it does not offer a measurement of MP but an
indirect and probably less reliable estimate (e.g., nonhomoge-
neous MP-lipofuscin ratio). Moreover, compared to double-
wavelength FAF, qAF is less reliable in detecting defined
variations in macular pigment distribution, such as the ring-like
pattern observed by some authors in the foveal area.35–37
Nevertheless, due to its lesser dependence on patients’ skills,
FIGURE 2. Bland-Altman plots showing the repeatability between two measurements. (A) Mean macular pigment optical density measured with the
MPS II and reported in optical density units. The plot shows the variability between two tests (MPODHFP1 and MPODHFP2). (B) Mean qAF measured
in the foveal area (qAFF; approximately 08–1.28) and reported in log qAF units. The plot shows the variability between two tests (qAF1 and qAF2) (C)
Mean qAF measured in the inner ring (qAF3; approximately 1.38–4.38) and reported in log qAF units. The plot shows the variability between two
tests (qAF1 and qAF2). (D) Mean qAF measured in the middle ring (qAF6; approximately 4.58–78) and reported in log qAF units. The plot shows the
variability between two tests (qAF1 and qAF2). (E) Mean qAF measured in the outer ring (qAF8; approximately 7.28–9.78) and reported in log qAF
units. The plot shows the variability between two tests (qAF1 and qAF2).
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faster execution, real-time guidance for satisfactory acquisition
of images, and its association with morphologic examinations
(pixel-to-pixel correlation with spectral domain OCT), it can be
used as an alternative indirect indicator of MP, of macular
health, and possibly of susceptibility to develop macular
degeneration.
This study has several limitations. The areas analyzed with
qAF and MPS II are slightly different (Fig. 4). The intrinsic limit
of single-wavelength FAF made it impossible to clearly localize
and quantify MP patterns of distribution (e.g., ring-like),
potentially affecting the correlation we reported, especially
in the qAF3 area. Moreover, a relatively small number of eyes
and most importantly healthy and young subjects were
enrolled; in older healthy subjects with some degree of nuclear
sclerosis, the correlation we found between measurements
could be different.
In conclusion, MPODAF values in central areas significantly
correlate with MPODHFP in a group of young healthy subjects.
However, qAF and HFP do not seem to be interchangeable.
They represent two opposite ways of estimating MP, suggesting
that patients would rather be followed with a single type of
technique.
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